# Combined Use of Immunoglobulin and Pulse Steroid Therapies in Severe Covid-19 Patients

> **NCT06223984** · PHASE4 · COMPLETED · sponsor: **Konya City Hospital** · enrollment: 178 (actual)

## Conditions studied

- Pulse Steroid and Immunoglobulins Drugs in Covid 19 Patients

## Interventions

- **DRUG:** pulse steroid and nanogam

## Key facts

- **NCT ID:** NCT06223984
- **Lead sponsor:** Konya City Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-30
- **Primary completion:** 2020-11-14
- **Final completion:** 2020-11-14
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2024-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06223984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06223984, "Combined Use of Immunoglobulin and Pulse Steroid Therapies in Severe Covid-19 Patients". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06223984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*